Introduced in the 1940s, Pap testing has been the single greatest contributor to the overall decline in cervical cancer. Then, the 1996 launch of the Hologic ThinPrep Pap test propelled screening success to new heights, contributing to a further 28% reduction in invasive cancers in the U.S. To date, ThinPrep has become the most widely used Pap test in the country,1 with hundreds of published, peer-reviewed studies demonstrating significant benefits over the conventional Pap s

We are proud to announce that we are now in Network with Cigna.